# Neuphoria Therapeutics Inc.: Form SCHEDULE 13D/A, filed Nov 28, 2025

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: SCHEDULE 13D/A
- Filed: 2025-11-28
- Accepted by EDGAR: Nov 28, 2025, 14:09 ET
- Period: not reported
- Accession: 0000905148-25-004191
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000090514825004191/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000090514825004191/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000090514825004191/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 28, 2025.
Source: SEC EDGAR, the filing index for accession 0000905148-25-004191. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.